nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.744	1	CbGbCtD
Telmisartan—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00508	0.0226	CcSEcCtD
Telmisartan—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.00467	0.0208	CcSEcCtD
Telmisartan—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.00444	0.0198	CcSEcCtD
Telmisartan—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.00444	0.0198	CcSEcCtD
Telmisartan—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.00432	0.0192	CcSEcCtD
Telmisartan—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00432	0.0192	CcSEcCtD
Telmisartan—PPARG—forelimb—amyotrophic lateral sclerosis	0.00431	0.221	CbGeAlD
Telmisartan—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00393	0.0175	CcSEcCtD
Telmisartan—PPARG—hindlimb—amyotrophic lateral sclerosis	0.00388	0.199	CbGeAlD
Telmisartan—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00387	0.0172	CcSEcCtD
Telmisartan—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00339	0.0151	CcSEcCtD
Telmisartan—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00336	0.015	CcSEcCtD
Telmisartan—PPARG—appendage—amyotrophic lateral sclerosis	0.00333	0.171	CbGeAlD
Telmisartan—Gout—Riluzole—amyotrophic lateral sclerosis	0.00328	0.0146	CcSEcCtD
Telmisartan—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00323	0.0144	CcSEcCtD
Telmisartan—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00306	0.0136	CcSEcCtD
Telmisartan—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00299	0.0133	CcSEcCtD
Telmisartan—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00281	0.0125	CcSEcCtD
Telmisartan—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00268	0.0119	CcSEcCtD
Telmisartan—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00265	0.0118	CcSEcCtD
Telmisartan—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.0026	0.0116	CcSEcCtD
Telmisartan—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00255	0.0114	CcSEcCtD
Telmisartan—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00254	0.0113	CcSEcCtD
Telmisartan—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00248	0.0111	CcSEcCtD
Telmisartan—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00247	0.011	CcSEcCtD
Telmisartan—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00245	0.0109	CcSEcCtD
Telmisartan—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00236	0.0105	CcSEcCtD
Telmisartan—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00234	0.0104	CcSEcCtD
Telmisartan—Purpura—Riluzole—amyotrophic lateral sclerosis	0.0023	0.0103	CcSEcCtD
Telmisartan—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00228	0.0102	CcSEcCtD
Telmisartan—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00989	CcSEcCtD
Telmisartan—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00973	CcSEcCtD
Telmisartan—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00955	CcSEcCtD
Telmisartan—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00903	CcSEcCtD
Telmisartan—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00202	0.009	CcSEcCtD
Telmisartan—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00894	CcSEcCtD
Telmisartan—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00875	CcSEcCtD
Telmisartan—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00872	CcSEcCtD
Telmisartan—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00193	0.0086	CcSEcCtD
Telmisartan—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00855	CcSEcCtD
Telmisartan—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00832	CcSEcCtD
Telmisartan—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00822	CcSEcCtD
Telmisartan—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00819	CcSEcCtD
Telmisartan—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00799	CcSEcCtD
Telmisartan—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00789	CcSEcCtD
Telmisartan—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00787	CcSEcCtD
Telmisartan—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00766	CcSEcCtD
Telmisartan—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00762	CcSEcCtD
Telmisartan—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00762	CcSEcCtD
Telmisartan—Depression—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0076	CcSEcCtD
Telmisartan—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00751	CcSEcCtD
Telmisartan—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00747	CcSEcCtD
Telmisartan—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00747	CcSEcCtD
Telmisartan—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00741	CcSEcCtD
Telmisartan—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00727	CcSEcCtD
Telmisartan—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00721	CcSEcCtD
Telmisartan—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00719	CcSEcCtD
Telmisartan—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00715	CcSEcCtD
Telmisartan—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00696	CcSEcCtD
Telmisartan—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00686	CcSEcCtD
Telmisartan—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00681	CcSEcCtD
Telmisartan—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00679	CcSEcCtD
Telmisartan—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00676	CcSEcCtD
Telmisartan—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00674	CcSEcCtD
Telmisartan—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00672	CcSEcCtD
Telmisartan—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00671	CcSEcCtD
Telmisartan—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00639	CcSEcCtD
Telmisartan—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00635	CcSEcCtD
Telmisartan—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00621	CcSEcCtD
Telmisartan—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00618	CcSEcCtD
Telmisartan—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00617	CcSEcCtD
Telmisartan—Chills—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00614	CcSEcCtD
Telmisartan—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00611	CcSEcCtD
Telmisartan—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00599	CcSEcCtD
Telmisartan—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00595	CcSEcCtD
Telmisartan—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00587	CcSEcCtD
Telmisartan—Tension—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00584	CcSEcCtD
Telmisartan—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00583	CcSEcCtD
Telmisartan—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00578	CcSEcCtD
Telmisartan—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00576	CcSEcCtD
Telmisartan—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00573	CcSEcCtD
Telmisartan—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00553	CcSEcCtD
Telmisartan—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00124	0.0055	CcSEcCtD
Telmisartan—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00544	CcSEcCtD
Telmisartan—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00537	CcSEcCtD
Telmisartan—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00535	CcSEcCtD
Telmisartan—Syncope—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00534	CcSEcCtD
Telmisartan—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00526	CcSEcCtD
Telmisartan—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00523	CcSEcCtD
Telmisartan—Cough—Riluzole—amyotrophic lateral sclerosis	0.00117	0.0052	CcSEcCtD
Telmisartan—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00514	CcSEcCtD
Telmisartan—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00507	CcSEcCtD
Telmisartan—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00507	CcSEcCtD
Telmisartan—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00507	CcSEcCtD
Telmisartan—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00505	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00503	CcSEcCtD
Telmisartan—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00501	CcSEcCtD
Telmisartan—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00496	CcSEcCtD
Telmisartan—PPARG—embryo—amyotrophic lateral sclerosis	0.00111	0.0566	CbGeAlD
Telmisartan—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00486	CcSEcCtD
Telmisartan—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00486	CcSEcCtD
Telmisartan—Infection—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00483	CcSEcCtD
Telmisartan—Shock—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00478	CcSEcCtD
Telmisartan—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00477	CcSEcCtD
Telmisartan—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00476	CcSEcCtD
Telmisartan—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00474	CcSEcCtD
Telmisartan—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00472	CcSEcCtD
Telmisartan—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0047	CcSEcCtD
Telmisartan—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00463	CcSEcCtD
Telmisartan—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00454	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000994	0.00443	CcSEcCtD
Telmisartan—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000987	0.0044	CcSEcCtD
Telmisartan—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00098	0.00436	CcSEcCtD
Telmisartan—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000973	0.00433	CcSEcCtD
Telmisartan—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00097	0.00432	CcSEcCtD
Telmisartan—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00096	0.00428	CcSEcCtD
Telmisartan—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000948	0.00422	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000942	0.0042	CcSEcCtD
Telmisartan—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000941	0.00419	CcSEcCtD
Telmisartan—Pain—Riluzole—amyotrophic lateral sclerosis	0.000933	0.00416	CcSEcCtD
Telmisartan—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000933	0.00416	CcSEcCtD
Telmisartan—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000899	0.004	CcSEcCtD
Telmisartan—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000892	0.00397	CcSEcCtD
Telmisartan—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000867	0.00386	CcSEcCtD
Telmisartan—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000863	0.00384	CcSEcCtD
Telmisartan—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000863	0.00384	CcSEcCtD
Telmisartan—AGTR1—medulla oblongata—amyotrophic lateral sclerosis	0.000859	0.044	CbGeAlD
Telmisartan—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000804	0.00358	CcSEcCtD
Telmisartan—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000783	0.00349	CcSEcCtD
Telmisartan—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000772	0.00344	CcSEcCtD
Telmisartan—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000747	0.00333	CcSEcCtD
Telmisartan—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000722	0.00321	CcSEcCtD
Telmisartan—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000694	0.00309	CcSEcCtD
Telmisartan—Rash—Riluzole—amyotrophic lateral sclerosis	0.000688	0.00306	CcSEcCtD
Telmisartan—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000687	0.00306	CcSEcCtD
Telmisartan—Headache—Riluzole—amyotrophic lateral sclerosis	0.000684	0.00304	CcSEcCtD
Telmisartan—PPARG—RXR and RAR heterodimerization with other nuclear receptor—RARA—amyotrophic lateral sclerosis	0.000654	0.0568	CbGpPWpGaD
Telmisartan—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000648	0.00289	CcSEcCtD
Telmisartan—AGTR1—nervous system—amyotrophic lateral sclerosis	0.000645	0.0331	CbGeAlD
Telmisartan—AGTR1—central nervous system—amyotrophic lateral sclerosis	0.000621	0.0318	CbGeAlD
Telmisartan—PPARG—nervous system—amyotrophic lateral sclerosis	0.000531	0.0272	CbGeAlD
Telmisartan—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000528	0.0458	CbGpPWpGaD
Telmisartan—PPARG—central nervous system—amyotrophic lateral sclerosis	0.000511	0.0262	CbGeAlD
Telmisartan—AGTR1—brain—amyotrophic lateral sclerosis	0.000493	0.0253	CbGeAlD
Telmisartan—PPARG—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.000483	0.0419	CbGpPWpGaD
Telmisartan—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000453	0.0232	CbGeAlD
Telmisartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000442	0.0384	CbGpPWpGaD
Telmisartan—PPARG—brain—amyotrophic lateral sclerosis	0.000406	0.0208	CbGeAlD
Telmisartan—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000404	0.0207	CbGeAlD
Telmisartan—PPARG—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.000381	0.0331	CbGpPWpGaD
Telmisartan—ABCB1—embryo—amyotrophic lateral sclerosis	0.000349	0.0179	CbGeAlD
Telmisartan—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.00032	0.0164	CbGeAlD
Telmisartan—PPARG—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.00032	0.0278	CbGpPWpGaD
Telmisartan—AGTR1—Peptide GPCRs—C5AR1—amyotrophic lateral sclerosis	0.000301	0.0261	CbGpPWpGaD
Telmisartan—CYP2C19—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000297	0.0258	CbGpPWpGaD
Telmisartan—ABCG2—brain—amyotrophic lateral sclerosis	0.00026	0.0133	CbGeAlD
Telmisartan—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000223	0.0114	CbGeAlD
Telmisartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000208	0.0181	CbGpPWpGaD
Telmisartan—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000199	0.0102	CbGeAlD
Telmisartan—PPARG—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.00018	0.0157	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000175	0.0152	CbGpPWpGaD
Telmisartan—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000168	0.00859	CbGeAlD
Telmisartan—PPARG—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000165	0.0144	CbGpPWpGaD
Telmisartan—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000161	0.00827	CbGeAlD
Telmisartan—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000158	0.00809	CbGeAlD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	0.000151	0.0131	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—C5AR1—amyotrophic lateral sclerosis	0.000141	0.0123	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000141	0.0122	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000133	0.0115	CbGpPWpGaD
Telmisartan—ABCB1—brain—amyotrophic lateral sclerosis	0.000128	0.00657	CbGeAlD
Telmisartan—PPARG—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000125	0.0109	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000125	0.0108	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000124	0.0107	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000113	0.00981	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000113	0.00981	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000105	0.00916	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000105	0.00912	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	9.88e-05	0.00858	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	9.71e-05	0.00843	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	9.64e-05	0.00837	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	9.6e-05	0.00834	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	9.48e-05	0.00824	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	8.96e-05	0.00778	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	8.9e-05	0.00773	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	8.56e-05	0.00743	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—amyotrophic lateral sclerosis	8.53e-05	0.00741	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	8.49e-05	0.00738	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	8.43e-05	0.00732	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—ZNF470—amyotrophic lateral sclerosis	7.97e-05	0.00692	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	7.92e-05	0.00688	CbGpPWpGaD
Telmisartan—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	7.77e-05	0.00675	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	7.49e-05	0.0065	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	7.37e-05	0.0064	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	7.22e-05	0.00627	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—SMN1—amyotrophic lateral sclerosis	6.77e-05	0.00588	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	6.77e-05	0.00588	CbGpPWpGaD
Telmisartan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	6.67e-05	0.00579	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	6.59e-05	0.00572	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	6.41e-05	0.00557	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	6.37e-05	0.00553	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	6.26e-05	0.00544	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	6.17e-05	0.00536	CbGpPWpGaD
Telmisartan—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.11e-05	0.00531	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—ZNF746—amyotrophic lateral sclerosis	6.04e-05	0.00524	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	5.86e-05	0.00509	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.78e-05	0.00502	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	5.74e-05	0.00498	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—PFN1—amyotrophic lateral sclerosis	5.58e-05	0.00485	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	5.54e-05	0.00481	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.53e-05	0.0048	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—VAPB—amyotrophic lateral sclerosis	5.5e-05	0.00478	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—TPK1—amyotrophic lateral sclerosis	5.5e-05	0.00478	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	5.23e-05	0.00454	CbGpPWpGaD
Telmisartan—ABCG2—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	5.16e-05	0.00448	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	5.14e-05	0.00446	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.13e-05	0.00446	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—VAPA—amyotrophic lateral sclerosis	5.03e-05	0.00437	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.88e-05	0.00424	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.88e-05	0.00424	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—IGF1—amyotrophic lateral sclerosis	4.79e-05	0.00416	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—VAPB—amyotrophic lateral sclerosis	4.69e-05	0.00408	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—TPK1—amyotrophic lateral sclerosis	4.69e-05	0.00408	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.68e-05	0.00406	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—FIG4—amyotrophic lateral sclerosis	4.4e-05	0.00382	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.38e-05	0.0038	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.35e-05	0.00378	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—VAPA—amyotrophic lateral sclerosis	4.29e-05	0.00373	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.26e-05	0.0037	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	4.19e-05	0.00363	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	4.14e-05	0.0036	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	4.14e-05	0.00359	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	4.1e-05	0.00356	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	4.08e-05	0.00354	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.99e-05	0.00347	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—DAO—amyotrophic lateral sclerosis	3.98e-05	0.00345	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	3.92e-05	0.00341	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.89e-05	0.00338	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—FUS—amyotrophic lateral sclerosis	3.89e-05	0.00338	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	3.77e-05	0.00327	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—FIG4—amyotrophic lateral sclerosis	3.75e-05	0.00326	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	3.71e-05	0.00322	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	3.66e-05	0.00317	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.62e-05	0.00314	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	3.6e-05	0.00312	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.57e-05	0.0031	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.49e-05	0.00303	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.49e-05	0.00303	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	3.49e-05	0.00303	CbGpPWpGaD
Telmisartan—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.44e-05	0.00299	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	3.42e-05	0.00297	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	3.42e-05	0.00297	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.4e-05	0.00296	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—DAO—amyotrophic lateral sclerosis	3.39e-05	0.00295	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	3.28e-05	0.00285	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—RARA—amyotrophic lateral sclerosis	3.17e-05	0.00275	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	3.15e-05	0.00274	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	3.13e-05	0.00272	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.11e-05	0.0027	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.03e-05	0.00264	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.03e-05	0.00264	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PLB1—amyotrophic lateral sclerosis	3.01e-05	0.00262	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	2.99e-05	0.0026	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.91e-05	0.00253	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.89e-05	0.00251	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GSR—amyotrophic lateral sclerosis	2.78e-05	0.00242	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.74e-05	0.00238	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.72e-05	0.00236	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.71e-05	0.00235	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.58e-05	0.00224	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PLB1—amyotrophic lateral sclerosis	2.57e-05	0.00223	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	2.54e-05	0.0022	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.53e-05	0.0022	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.49e-05	0.00217	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	2.47e-05	0.00215	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.47e-05	0.00215	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.44e-05	0.00212	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSR—amyotrophic lateral sclerosis	2.37e-05	0.00206	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.33e-05	0.00203	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CHAT—amyotrophic lateral sclerosis	2.28e-05	0.00198	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.21e-05	0.00192	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.19e-05	0.0019	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	2.16e-05	0.00188	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.16e-05	0.00188	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	2.14e-05	0.00186	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	2.12e-05	0.00184	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.08e-05	0.00181	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	2.04e-05	0.00177	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CHAT—amyotrophic lateral sclerosis	1.95e-05	0.00169	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	1.93e-05	0.00168	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	1.9e-05	0.00165	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	1.9e-05	0.00165	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.88e-05	0.00163	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	1.85e-05	0.00161	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	1.85e-05	0.00161	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	1.84e-05	0.0016	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.83e-05	0.00159	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.78e-05	0.00155	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.78e-05	0.00154	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.77e-05	0.00154	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	1.73e-05	0.00151	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	1.73e-05	0.0015	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.69e-05	0.00147	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	1.67e-05	0.00145	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.64e-05	0.00143	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.64e-05	0.00143	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.62e-05	0.00141	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.61e-05	0.0014	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.57e-05	0.00137	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	1.52e-05	0.00132	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.5e-05	0.00131	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.48e-05	0.00128	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.46e-05	0.00127	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.43e-05	0.00124	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.42e-05	0.00123	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.41e-05	0.00123	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.39e-05	0.00121	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	1.37e-05	0.00119	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.34e-05	0.00117	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.34e-05	0.00116	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.23e-05	0.00107	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.22e-05	0.00106	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP9—amyotrophic lateral sclerosis	1.2e-05	0.00104	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.15e-05	0.000999	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.15e-05	0.000999	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.13e-05	0.00098	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.08e-05	0.000939	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	1.08e-05	0.000934	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.07e-05	0.000928	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.05e-05	0.00091	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.04e-05	0.000902	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.01e-05	0.000881	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.63e-06	0.000836	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	9.59e-06	0.000833	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.56e-06	0.00083	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	9.36e-06	0.000813	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—APOE—amyotrophic lateral sclerosis	9.28e-06	0.000806	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	9.06e-06	0.000787	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.9e-06	0.000773	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.73e-06	0.000758	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—APOE—amyotrophic lateral sclerosis	7.92e-06	0.000688	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	7.87e-06	0.000684	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	7.69e-06	0.000667	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.64e-06	0.000663	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.35e-06	0.000639	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.18e-06	0.000624	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.02e-06	0.00061	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	6.85e-06	0.000595	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.36e-06	0.000553	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	5.78e-06	0.000502	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.66e-06	0.000491	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.43e-06	0.000471	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.35e-06	0.000464	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.92e-06	0.000428	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.8e-06	0.000417	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.23e-06	0.000368	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.13e-06	0.000359	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.96e-06	0.000344	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.89e-06	0.000338	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.8e-06	0.00033	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.63e-06	0.000315	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	3.2e-06	0.000278	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	3.12e-06	0.000271	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.19e-06	0.00019	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.14e-06	0.000186	CbGpPWpGaD
